185 results
8-K
EX-99.1
BMY
Bristol-Myers Squibb Co.
25 Apr 24
Bristol Myers Squibb Reports First Quarter Financial Results for 2024
7:47am
Statements" and "Use of Non-GAAP Financial Information."
Environmental, Social & Governance (ESG)
As a leading biopharmaceutical company, Bristol
DEFA14A
BMY
Bristol-Myers Squibb Co.
22 Apr 24
Additional proxy soliciting materials
8:16am
STRATEGY & GOVERNANCE Conducted a revised global ESG materiality assessment Expanded ESG operating model to further align with company strategy … Established ESG Council in 2022 as primary governance body for all ESG matters As a leading biopharma company, we understand our responsibility extends well
8-K
EX-99.1
2wbox9hh
2 Feb 24
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2023
7:46am
8-K/A
jecjas2ahu9semwwmp
31 Oct 23
Departure of Directors or Certain Officers
4:30pm
8-K
EX-99.1
f1j 5v01k72e2y7
26 Oct 23
Bristol Myers Squibb Reports Third Quarter Financial Results for 2023
7:44am
8-K
EX-99.1
4dpho8iyea9u2qd ok
27 Jul 23
Bristol Myers Squibb Reports Second Quarter Financial Results for 2023
7:50am
8-K
EX-99.1
36jq4n
27 Apr 23
Bristol Myers Squibb Reports First Quarter Financial Results for 2023
7:45am
DEFA14A
hyeu1l4
10 Apr 23
Additional proxy soliciting materials
5:12pm
8-K
EX-99.1
aeofqxl95yccrt6s54oa
26 Oct 22
Bristol Myers Squibb Reports Third Quarter Financial Results for 2022
7:48am
8-K
EX-99.1
02a4ykd463w1lgc6e28j
27 Jul 22
Bristol Myers Squibb Reports Second Quarter Financial Results for 2022
7:44am
8-K
EX-99.1
f3ohnm3ihj wzdp5
29 Apr 22
Bristol Myers Squibb Reports First Quarter Financial Results for 2022
7:42am
DEFA14A
pgcz0m 8fjlvk
20 Apr 22
Additional proxy soliciting materials
4:30pm
PX14A6G
xis3huf1f o7hs51xl
5 Apr 22
Letter to shareholders
4:53pm
8-K
EX-99.1
s7wclu6t
4 Feb 22
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2021
7:50am